Pharmacists and Interns May Administer Childhood and COVID-19 Vaccines

Posted in Latest News on October 2, 2020.

Emergency Order DOH No. 20-014 allows licensed pharmacists and registered pharmacy interns to administer FDA approved vaccines to individuals, including those under 18 years of age.

For purposes of preparing for, responding to, and mitigating any effect of COVID-19, Emergency Order 20-014 was filed suspending the provision of section 465.189(1), Florida Statutes, to the extent necessary to authorize a pharmacist or registered pharmacy intern certified under section 465.189(6), Florida Statutes, to administer vaccines approved or licensed by the Food and Drug Administration (FDA) to individuals under 18 years of age, upon receipt of medical consent for a minor, as required by section 743.0645, Florida Statutes.

For purposes of preparing for, responding to, and mitigating any effect of COVID-19, this Emergency Order suspends the provision of section 465.189(1)(a), Florida Statutes, to the extent necessary to allow a pharmacist or registered pharmacy intern certified under section 465.189(6), Florida Statutes, to administer vaccines ordered and administered according to the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices (ACIP) immunization schedules and any vaccine approved by the FDA to immunize individuals against COVID-19.

Pharmacists are required to report all patient vaccination details to Florida SHOTS. Click here for more information on enrolling and reporting requirements.

The full version of the State Surgeon General’s Emergency Order may be found at https://floridahealthcovid19.gov/wp-content/uploads/2020/10/DOH-Emergency-Order-No-20-014.pdf.



More Latest News

Gov. DeSantis declares State of Emergency in FL for Tropical Depression Fred
August 13, 2021

Please click here for more information on filling prescriptions under the Emergency Order issued by Governor DeSantis Continue reading


Monoclonal Antibody Therapy Authorized for COVID-19
August 5, 2021

Important Updates Regarding the Revised Emergency Use Authorization, Direct Order, and Reporting Process for REGEN-COV Monoclonal Antibody Therapy Continue reading